相关实验视频

Updated: Sep 10, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

化疗调节PD-L1表达,其与免疫检查点阻断的结合需要精确

Xiayue Zhang¹, Henglu Cui¹, Xiaoyu Zhang²

¹Department of Pathogenic Biology, School of Medicine, Nantong University, Nantong 226001, China; Laboratory of Medical Science, School of Medicine, Nantong University, Nantong 226001, China.

Critical reviews in oncology/hematology

|August 21, 2025

概括

将化疗与免疫检查点阻断 (ICB) 结合起来, 量身定制化疗选择是最大限度地提高这种联合治疗效果的关键.

科学领域:

癌症学
免疫学
药理学

背景情况:

免疫检查点封锁 (ICB) 已经改变了先进的癌症治疗,
化疗直接针对瘤细胞,并可以通过抗原释放来增强抗瘤免疫力.
结合ICB和化疗是一种有前途的策略,目前正在进行广泛的临床研究.

研究的目的:

系统地审查化疗剂如何影响PD-1/PD-L1免疫检查点.
总结化疗和ICB在各种癌症类型的综合作用.
突出个人化疗选择组合治疗的重要性.

主要方法:

对化疗对PD-1/PD-L1表达的影响的现有文献进行系统评估.
对化疗和ICB协同作用的临床试验数据的审查.
分析化疗对免疫细胞群体和抗瘤免疫力的影响.

主要成果:

化疗可以调节PD- L1表达,可能影响ICB的疗效.
组合疗法在不同类型的癌症中显示出显著的前景.
化疗会影响免疫细胞群体,需要仔细选择药物和剂量.

结论:

结合化疗和ICB的个性化组合疗法有可能改善癌症患者的治疗结果.
优化化疗选择对于最大化联合治疗的协同效益至关重要.
需要进一步的研究来充分阐明化疗与免疫系统在癌症治疗中的复杂相互作用.

关键词:

化学疗法多克索鲁比辛免疫检查点封锁美国其他类型个性化治疗

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...